- Open Access
Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
Journal for ImmunoTherapy of Cancer volume 7, Article number: 349 (2019)
- The original article was published in Journal for ImmunoTherapy of Cancer 2019 7:288
Correction to: J ImmunoTher Cancer (2019) 7:288
In Fig. 2:
A: Red font “MHC-I (MFI x 103)” should change to black font;
C: Red font “0.07” and “M-MDSC” should change to black font.
In Additional file 1: Figure S1, S2:
S1: Red font “Spleen” and “Tumor” should change to black font;
S2: Red font “C”, “D”, “E”, “F”, “G”, “H” should change to black font.
The correct version of the figures can be found below.
The corrections have been implemented in the original article as well.
We apologize for the inconvenience.
Metzger, et al. J ImmunoTher Cancer. 2019;7:288. https://doi.org/10.1186/s40425-019-0778-7.
The original version of this article was revised: the authors have reported that Figure 2 and S2 partially show red scripts.
Additional file 1: Figure S1.. Gating strategy for the identification of MDSC populations. Figure S2. Poly(I:C)c reduces macrophage frequency and activates macrophages, cDC, B and NK cells. Figure S3. Poly(I:C)c triggers transcriptional reprogramming of MDSC. Figure S4. Significantly regulated genes in PMN- and M-MDSC upon poly(I:C)c therapy.
About this article
Cite this article
Metzger, P., Kirchleitner, S.V., Kluge, M. et al. Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. j. immunotherapy cancer 7, 349 (2019). https://doi.org/10.1186/s40425-019-0830-7